Literature DB >> 9479298

Characteristics of uveitis presenting for the first time in the elderly.

K Chatzistefanou1, N N Markomichelakis, W Christen, M Soheilian, C S Foster.   

Abstract

OBJECTIVE: This study aimed to describe the clinical characteristics of uveitis presenting de novo in the elderly.
DESIGN: The study design was a description of a retrospectively identified case series. PARTICIPANTS: A population of 138 patients (209 eyes) with uveitis beginning after age 60 was analyzed.
RESULTS: Uveitis in the elderly accounted for 10.4% of the authors' uveitis population. The localization of uveitis was anterior in 56.5% of patients, intermediate uveitis was diagnosed in two patients (1.4%), posterior uveitis was found in 25.4%, while 16.7% of patients presented with panuveitis. Idiopathic uveitis accounted for the majority of cases (31.2%), whereas herpes zoster ophthalmicus (11.6%), herpes simplex virus (6.5%), presumed sarcoidosis (5.8%), syphilis (4.3%) ankylosing spondylitis (4.3%), and birdshot chorioretinopathy (3.6%) were the most frequent specific diagnostic entities. Secondary elevation of intraocular pressure was common (67 eyes, or 32%). The development of macular edema complicated 28.7% of cases (60 eyes). Two cases of intraocular lymphoma were identified in 19 diagnostic vitreous biopsy specimens. Fifty-two percent of eyes retained visual acuity of 20/40 or more; 32.6% had final visual acuity worse than 20/100.
CONCLUSIONS: Uveitis presenting for the first time in the elderly is not uncommon. Idiopathic uveitis accounts for the majority of cases, and herpes zoster ophthalmicus and herpes simplex virus are particularly prevalent. Intraocular lymphoma does not predominate in this age group. With adequate control of intraocular inflammation and its sequelae, the visual prognosis in patients in this age group with uveitis is relatively good.

Entities:  

Mesh:

Year:  1998        PMID: 9479298     DOI: 10.1016/s0161-6420(98)93523-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

Review 1.  Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors:  Rajen Gupta; Philip I Murray
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  Intraocular Inflammation in Diabetic Populations.

Authors:  Wajiha J Kheir; Huda A Sheheitli; Rola N Hamam
Journal:  Curr Diab Rep       Date:  2017-08-08       Impact factor: 4.810

3.  Neoplastic masquerade syndromes in patients with uveitis.

Authors:  Landon K Grange; Amr Kouchouk; Monica D Dalal; Susan Vitale; Robert B Nussenblatt; Chi-Chao Chan; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2013-11-06       Impact factor: 5.258

4.  Age distribution of patients presenting with uveitis.

Authors:  Holger Baatz; Gábor B Scharioth; Diego de Ortueta; Mitrofanis Pavlidis
Journal:  Open Ophthalmol J       Date:  2007-12-17

5.  The risk of complications of uveitis in a district hospital cohort.

Authors:  R Maini; J O'Sullivan; A Reddy; S Watson; C Edelsten
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

6.  Classification Criteria for Intermediate Uveitis, Non-Pars Planitis Type.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-09       Impact factor: 5.488

7.  Classification Criteria for Birdshot Chorioretinitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-15       Impact factor: 5.488

Review 8.  Uveitis in the Aging Eye: Incidence, Patterns, and Differential Diagnosis.

Authors:  Marwan R Abdulaal; Bachir H Abiad; Rola N Hamam
Journal:  J Ophthalmol       Date:  2015-05-18       Impact factor: 1.909

Review 9.  Birdshot retinochoroidopathy.

Authors:  Albert T Vitale
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep

10.  Clinical Features, Diagnosis, Management and Prognosis of Primary Intraocular Lymphoma.

Authors:  Xin-Yu Zhao; Tian-Tian Cheng; Li-Hui Meng; Wen-Fei Zhang; You-Xin Chen
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.